Advanced search
Publication Cover
Expert Review of Clinical Pharmacology Volume 13, 2020 - Issue 9
Submit an article Journal homepage
6,878
Views
18
CrossRef citations to date
0
Altmetric
Editorial

Melatonin as a putative protection against myocardial injury in COVID-19 infection

Fedor Simkoa Institute of Pathophysiology, Faculty of Medicine, Comenius University, Bratislava, Slovak Republic;b 3rd Department of Internal Medicine, Faculty of Medicine, Comenius University, Bratislava, Slovak Republic;c Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovak RepublicCorrespondence[email protected]
View further author information
,
Jaroslav Hrenaka Institute of Pathophysiology, Faculty of Medicine, Comenius University, Bratislava, Slovak Republic;d Department of Cardiovascular Surgery, Inselspital – University Hospital of Bern, Bern, SwitzerlandView further author information
,
Alberto Dominguez-Rodrigueze Department of Cardiology, Hospital Universitario de Canarias, Santa Cruz de Tenerife, SpainView further author information
&
Russel J. Reiterf Department of Cell Systems and Anatomy, UT Health San Antonio, San Antonio, TX, USAView further author information
Pages 921-924 | Received 08 Jul 2020, Accepted 20 Aug 2020, Published online: 07 Sep 2020

References

  • Madjid M, Safavi-Naeini P, Solomon SD, et al. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020 Mar 27;5:831.
  • Wu L, O’Kane AM, Peng H, et al. SARS-CoV-2 and cardiovascular complications: from molecular mechanisms to pharmaceutical management. Biochem Pharmacol. 2020;178:114114.
  • Akhmerov A, Marbán E. COVID-19 and the heart. Circ Res. 2020;126(10):1443–1455.
  • Hanff TC, Harhay MO, Brown TS, et al. Is there an association between COVID-19 mortality and the renin-angiotensin system-a call for epidemiologic investigations. Clin Infect Dis. 2020;71:870–874.
  • Huang C, Wang Y, Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.
  • Fu Z, Jiao Y, Wang J, et al. Cardioprotective role of melatonin in acute myocardial infarction. Front Physiol. 2020;11:366. eCollection 2020.
  • Lochner A, Marais E, Huisamen B. Melatonin and cardioprotection against ischaemia/reperfusion injury: what’s new? A review. J Pineal Res. 2018;65(1):e12490.
  • Reiter RJ, Tan DX, Rosales-Corral S, et al. The universal nature, unequal distribution and antioxidant functions of melatonin and its derivatives. Mini Rev Med Chem. 2013;13:373–384.
  • Reiter RJ, Ma Q, Sharma R. Melatonin in mitochondria: mitigating clear and present dangers. Physiology (Bethesda). 2020;35:86–95.
  • Hardeland R. Aging, melatonin, and the pro- and anti-inflammatory networks. Int J Mol Sci. 2019;20:1223.
  • Simko F, Baka T, Paulis L, et al. Elevated heart rate and nondipping heart rate as potential targets for melatonin: a review. J Pineal Res. 2016;61:127–137.
  • Reiter RJ, Ma Q, Sharma M. Treatment of ebola and other infectious diseases: melatonin “goes viral”. Melat Res. 2020;3:43–57.
  • Zhang R, Wang X, Ni L, et al. COVID-19: melatonin as a potential adjuvant treatment. Life Sci. 2020;250:117583.
  • Anderson G, Reiter RJ. Melatonin: roles in influenza, Covid-19, and other viral infections. Rev Med Virol. 2020;30(3):e2109.
  • Sang Y, Gu X, Pan L, et al. Melatonin ameliorates coxsackievirus B3-induced myocarditis by regulating apoptosis and autophagy. Front Pharmacol. 2018;9:1384.
  • Ouyang H, Zhong J, Lu J, et al. Inhibitory effect of melatonin on Mst1 ameliorates myocarditis through attenuating ER stress and mitochondrial dysfunction. J Mol Histol. 2019;50:405–415.
  • Gürses I, Özeren M, Serin M, et al. Histopathological evaluation of melatonin as a protective agent in heart injury induced by radiation in a rat model. Pathol Res Pract. 2014;210:863–871.
  • Oliveira LG, Kuehn CC, Dos Santos CD, et al. Protective actions of melatonin against heart damage during chronic Chagas disease. Acta Trop. 2013;128:652–658.
  • Simko F, Paulis L. Antifibrotic effect of melatonin-perspective protection in hypertensive heart disease. Int J Cardiol. 2013;3:2876–2877.
  • Simko F, Bednarova-Repova K, Krajcirovicova K, et al. Melatonin reduces cardiac remodeling and improves survival in rats with isoproterenol-induced heart failure. J Pineal Res. 2014;57:177–184.
  • Simko F, Reiter RJ. Is melatonin deficiency a unifying pathomechanism of high risk patients with COVID-19? Life Sci. 2020;11790. DOI: https://doi.org/10.1016/j.lfs.2020.117902.
  • Baltatu OC, Senar S, Campos LA, et al. Cardioprotective melatonin: translating from proof-of-concept studies to therapeutic use. Int J Mol Sci. 2019;20(18):4342. .
  • Reiter RJ, Abreu-Gonzalez P, Marik PE, et al. Therapeutic algorithm for use of melatonin in patients with COVID-19. Front Med (Lausanne). 2020 May 15;7:226. eCollection 2020.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.